CRUST
发表于 2025-3-21 17:37:18
书目名称Novel Synthetic Drugs in Migraine影响因子(影响力)<br> http://figure.impactfactor.cn/if/?ISSN=BK0668457<br><br> <br><br>书目名称Novel Synthetic Drugs in Migraine影响因子(影响力)学科排名<br> http://figure.impactfactor.cn/ifr/?ISSN=BK0668457<br><br> <br><br>书目名称Novel Synthetic Drugs in Migraine网络公开度<br> http://figure.impactfactor.cn/at/?ISSN=BK0668457<br><br> <br><br>书目名称Novel Synthetic Drugs in Migraine网络公开度学科排名<br> http://figure.impactfactor.cn/atr/?ISSN=BK0668457<br><br> <br><br>书目名称Novel Synthetic Drugs in Migraine被引频次<br> http://figure.impactfactor.cn/tc/?ISSN=BK0668457<br><br> <br><br>书目名称Novel Synthetic Drugs in Migraine被引频次学科排名<br> http://figure.impactfactor.cn/tcr/?ISSN=BK0668457<br><br> <br><br>书目名称Novel Synthetic Drugs in Migraine年度引用<br> http://figure.impactfactor.cn/ii/?ISSN=BK0668457<br><br> <br><br>书目名称Novel Synthetic Drugs in Migraine年度引用学科排名<br> http://figure.impactfactor.cn/iir/?ISSN=BK0668457<br><br> <br><br>书目名称Novel Synthetic Drugs in Migraine读者反馈<br> http://figure.impactfactor.cn/5y/?ISSN=BK0668457<br><br> <br><br>书目名称Novel Synthetic Drugs in Migraine读者反馈学科排名<br> http://figure.impactfactor.cn/5yr/?ISSN=BK0668457<br><br> <br><br>
lanugo
发表于 2025-3-22 00:14:48
http://reply.papertrans.cn/67/6685/668457/668457_2.png
tolerance
发表于 2025-3-22 01:53:17
http://reply.papertrans.cn/67/6685/668457/668457_3.png
人造
发表于 2025-3-22 05:17:05
http://reply.papertrans.cn/67/6685/668457/668457_4.png
STANT
发表于 2025-3-22 10:22:39
http://reply.papertrans.cn/67/6685/668457/668457_5.png
Cabg318
发表于 2025-3-22 14:32:02
Zavegepant,inical data are available regarding its therapeutic efficacy and safety profile. Data on metabolism, pharmacogenomics, and pharmacokinetics profile are limited, therefore new studies are needed to define its efficacy, safety, tolerability, and pharmacological interaction.
调味品
发表于 2025-3-22 20:13:32
Molecular Mechanisms of 5-HT1F Receptor Agonists,igraine. Updated evidence suggests that ditans exert their antimigraine effects by modulating the trigeminovascular system, while devoid of cardiovascular safety drawbacks shared by previous antimigraine drugs targeting 5-HT receptors, namely ergot-derivatives and triptans.
Picks-Disease
发表于 2025-3-22 22:39:34
Update on Old and Current Targets for Antimigraine Therapies,hese are effective with few side effects. In this chapter, we discuss mechanisms involved in the use of and treatment with the different medications and use their effectiveness to understand a bit more of the underlying biology of migraine.
考博
发表于 2025-3-23 04:36:12
Book 2022ith ditans (lasmiditan) and gepants (atogepant, ubrogepant, rimegepant, vazegepant). These drugs will provide additional options for people with migraine put at risk of side effects by other medications or with unsatisfactory response to previous drugs. There is now a sufficient amount of literature
opprobrious
发表于 2025-3-23 08:07:23
http://reply.papertrans.cn/67/6685/668457/668457_10.png